Transforming Treg Biology Into Therapeutics for MS & T1D
Time: 1:00 pm
day: Day Two Track A, PM
Details:
• Discussing a platform that enables quick TCR discovery and plug and play manufacturing
• Highlighting autologous Treg therapies for tissue specific auto immune diseases such as progressive MS and T1D
